Centessa Pharmaceuticals PLC ADR (CNTA) earnings · rev $15.0M
These earnings events as JSON? API free 100/dayCentessa Pharmaceuticals PLC ADR (CNTA) is a biotechnology company listed on US.
This CNTA earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported CNTA revenue for 2025-12-31 was $15.0M. Net income was -$197.5M. CNTA currently screens at market cap $6.15B.
When the next CNTA 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for CNTA. We will not invent a beat or miss.
Not investment advice. Full CNTA research stays on the stock page; the tape stays on the quote page.
CNTA earnings FAQ
What are CNTA's latest revenue and net income?
Latest cached Centessa Pharmaceuticals PLC ADR (CNTA) revenue for Dec 31, 2025 was $15.0M. Net income was -$197.5M. Statements: https://lician.com/financials/cnta
What is CNTA's latest diluted EPS?
Latest cached Centessa Pharmaceuticals PLC ADR (CNTA) diluted EPS for Dec 31, 2025 was -$1.46.
What period does the latest CNTA earnings print cover?
The latest cached Centessa Pharmaceuticals PLC ADR (CNTA) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
Where are CNTA earnings listed?
Cached earnings facts for Centessa Pharmaceuticals PLC ADR (CNTA) are listed at https://lician.com/earnings/cnta. Statements: https://lician.com/financials/cnta
Not investment advice.